Stock Events

Intuitive Surgical 

$454.93
991
-$6.19-1.34% Today

Statistics

Day High
-
Day Low
454.35
52W High
468.78
52W Low
254.85
Volume
1,727,535
Avg. Volume
1,844,214
Mkt Cap
161.66B
P/E Ratio
82.12
Dividend Yield
-
Dividend
-

Earnings

18JulConfirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
1.2
1.39
1.59
1.78
Expected EPS
1.54
Actual EPS
1.78

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ISRG. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap101.91B
Medtronic competes with Intuitive Surgical in the robotic-assisted surgery space, particularly with its Hugo robotic-assisted surgery system.
Johnson & Johnson
JNJ
Mkt Cap372.29B
Johnson & Johnson, through its subsidiary Auris Health, Inc., offers the Monarch Platform, a robotic technology for diagnostic and therapeutic procedures in the lung, competing in the robotic surgical space.
Smith & Nephew
SNN
Mkt Cap12.37B
Smith & Nephew offers the NAVIO Surgical System, a next-generation handheld robotics platform, and the CORI Surgical System, competing in the orthopedic robotic surgery market.
Zimmer Biomet
ZBH
Mkt Cap22.73B
Zimmer Biomet Holdings, Inc. competes with its ROSA Robotics platform, which includes solutions for knee, spine, and brain surgeries.
Stryker
SYK
Mkt Cap129.88B
Stryker Corporation competes with its Mako Robotic-Arm Assisted Surgery system, offering precision in orthopedic surgeries, directly competing in the robotic surgery market.
Globus Medical
GMED
Mkt Cap8.18B
Globus Medical, Inc. competes with its ExcelsiusGPS, a robotic navigation technology for spine surgery, entering the robotic surgery market.
Intuitive Surgical
ISRG
Mkt Cap161.39B
Intuitive Surgical directly competes with itself through continuous innovation and development of new systems and enhancements to its da Vinci surgical systems.
Baxter International
BAX
Mkt Cap18.01B
Baxter International Inc. competes in the broader surgical products and services market, offering a range of products that can be seen as complementary or competitive to robotic surgery solutions.
Boston Scientific
BSX
Mkt Cap114.03B
Boston Scientific Corporation competes in the medical devices market with a focus on minimally invasive surgeries, offering products that could compete with robotic surgery systems in certain applications.

Analyst Ratings

474.08$Average Price Target
The highest estimate is $520.
From 12 ratings within the last 6 months. This is not an investment recommendation.
Buy
75%
Hold
25%
Sell
0%

About

Health Technology
Medical Specialties
Manufacturing
Surgical and Medical Instrument Manufacturing
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
Show more...
CEO
Gary Guthart
Employees
13676
Country
US
ISIN
US46120E6023
WKN
000888024

Listings